GEOVAX LABS INC (GOVX) Stock News

Apple To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Friday

Mentions: AAPL ALNY MSTR KSS ...

GeoVax Labs price target lowered to $14 from $18 at D. Boral Capital

D. Boral Capital lowered the firm’s price target on GeoVax Labs (GOVX) to $14 from $18 and keeps a Buy rating on the shares. GeoVax has encountered a significant challenge following the termination of its BARDA-funded Phase 2b clinical trial for the GEO-CM04S1 COVID-19 vaccine, the firm says. This decision, made for the government’s convenience, halts a pivotal study that was set to evaluate GEO-CM04S1 against an approved mRNA vaccine in a 10,000-participant trial under Project NextGen. The abru

Mentions: TSLA NVDA PLTR AAPL

12 Health Care Stocks Moving In Tuesday's Intraday Session

Mentions: IBO PHIO APM SPRB ...